Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1968 1
1970 3
1972 1
1975 1
1976 2
1977 2
1978 5
1979 1
1982 1
1983 2
1985 1
1987 3
1988 1
1989 2
1990 2
1991 1
1992 4
1993 2
1994 4
1995 1
1997 6
1998 5
1999 5
2000 2
2001 2
2002 1
2003 4
2004 1
2005 5
2006 1
2007 3
2008 2
2009 2
2010 2
2011 1
2012 3
2013 1
2014 3
2015 5
2016 4
2017 4
2018 5
2019 7
2020 6
2021 8
2022 8
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L. Tapia-Galisteo A, et al. Among authors: harwood sl. Oncoimmunology. 2022 Feb 7;11(1):2034355. doi: 10.1080/2162402X.2022.2034355. eCollection 2022. Oncoimmunology. 2022. PMID: 35154908 Free PMC article.
Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery.
Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, McGuinness S, Parke R, Serpell J, Chan MTV, Painter T, McCluskey S, Minto G, Wallace S; Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Myles PS, et al. N Engl J Med. 2018 Jun 14;378(24):2263-2274. doi: 10.1056/NEJMoa1801601. Epub 2018 May 9. N Engl J Med. 2018. PMID: 29742967 Free article. Clinical Trial.
Radical Retrosynthesis.
Smith JM, Harwood SJ, Baran PS. Smith JM, et al. Among authors: harwood sj. Acc Chem Res. 2018 Aug 21;51(8):1807-1817. doi: 10.1021/acs.accounts.8b00209. Epub 2018 Aug 2. Acc Chem Res. 2018. PMID: 30070821 Free PMC article.
Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management.
Kumar K, Ponnuswamy A, Capstick TG, Chen C, McCabe D, Hurst R, Morrison L, Moore F, Gallardo M, Keane J, Harwood S, Sinnett T, Bryant S, Breen R, Kon OM, Lipman M, Loebinger MR, Dhasmana DJ. Kumar K, et al. Among authors: harwood s. Clin Med (Lond). 2024 Jan;24(1):100017. doi: 10.1016/j.clinme.2024.100017. Epub 2024 Jan 17. Clin Med (Lond). 2024. PMID: 38387207 Free PMC article. Review.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Blanco B, Ramírez-Fernández Á, Bueno C, Argemí-Muntadas L, Fuentes P, Aguilar-Sopeña Ó, Gutierrez-Agüera F, Zanetti SR, Tapia-Galisteo A, Díez-Alonso L, Segura-Tudela A, Castellà M, Marzal B, Betriu S, Harwood SL, Compte M, Lykkemark S, Erce-Llamazares A, Rubio-Pérez L, Jiménez-Reinoso A, Domínguez-Alonso C, Neves M, Morales P, Paz-Artal E, Guedan S, Sanz L, Toribio ML, Roda-Navarro P, Juan M, Menéndez P, Álvarez-Vallina L. Blanco B, et al. Among authors: harwood sl. Cancer Immunol Res. 2022 Apr 1;10(4):498-511. doi: 10.1158/2326-6066.CIR-21-0853. Cancer Immunol Res. 2022. PMID: 35362043 Free PMC article.
Anaphylaxis.
Harwood S. Harwood S. Nursing. 1997 Feb;27(2):33. Nursing. 1997. PMID: 9171602 No abstract available.
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.
Rubio-Pérez L, Lázaro-Gorines R, Harwood SL, Compte M, Navarro R, Tapia-Galisteo A, Bonet J, Blanco B, Lykkemark S, Ramírez-Fernández Á, Ferreras-Gutiérrez M, Domínguez-Alonso C, Díez-Alonso L, Segura-Tudela A, Hangiu O, Erce-Llamazares A, Blanco FJ, Santos C, Rodríguez-Peralto JL, Sanz L, Álvarez-Vallina L. Rubio-Pérez L, et al. Among authors: harwood sl. Oncoimmunology. 2023 Apr 24;12(1):2205336. doi: 10.1080/2162402X.2023.2205336. eCollection 2023. Oncoimmunology. 2023. PMID: 37114242 Free PMC article.
The coming of age of engineered multivalent antibodies.
Nuñez-Prado N, Compte M, Harwood S, Álvarez-Méndez A, Lykkemark S, Sanz L, Álvarez-Vallina L. Nuñez-Prado N, et al. Among authors: harwood s. Drug Discov Today. 2015 May;20(5):588-94. doi: 10.1016/j.drudis.2015.02.013. Epub 2015 Mar 7. Drug Discov Today. 2015. PMID: 25757598 Review.
Ouabain-induced cell signaling.
Harwood S, Yaqoob MM. Harwood S, et al. Front Biosci. 2005 Sep 1;10:2011-7. doi: 10.2741/1676. Front Biosci. 2005. PMID: 15970473 Review.
145 results